Promising new sources for pluripotent stem cells

Stem Cell Reviews and Reports

Volumn 6, Issue 1, 2010, Pages 15-26

  Leeb, Christian ^a   Jurga, Marcin ^b   McGuckin, Colin ^b   Moriggl, Richard ^a   Kenner, Lukas ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CTI LYON   (France)

^c Institute for Clinical Pathology   (Austria)

Author keywords

Induced pluripotent stem cell; Pluripotency; Stem cell; Therapy; Umbilical cord

Indexed keywords

ADULT STEM CELL; ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; EMBRYO RESEARCH; FETUS BLOOD; HUMAN; PHYSIOLOGY; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ADULT STEM CELLS; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYO RESEARCH; FETAL BLOOD; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; RISK ASSESSMENT; STEM CELL TRANSPLANTATION;

IPS;

EID: 77949335754     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-009-9102-0     Document Type: Article

References (142)

1. Amit, M., Carpenter, M. K., Inokuma, M. S., et al. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Developmental Biology, 227(2), 271-278.
2. Sartipy, P., Bjorquist, P., Strehl, R., & Hyllner, J. (2007). The application of human embryonic stem cell technologies to drug discovery. Drug Discovery Today, 12(17-18), 688-699.
3. Keirstead, H. S., Nistor, G., Bernal, G., et al. (2005). Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. The Journal of Neuroscience, 25(19), 4694-4705.
4. Amariglio, N., Hirshberg, A., Scheithauer, B. W., et al. (2009). Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Medicine, 6(2), e1000029.
5. Gurdon, J. B., & Melton, D. A. (2008). Nuclear reprogramming in cells. Science, 322(5909), 1811-1815.
6. Cowan, C. A., Atienza, J., Melton, D. A., & Eggan, K. (2005). Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science, 309(5739), 1369-1373.
7. Matsumura, H., Tada, M., Otsuji, T., et al. (2007). Targeted chromosome elimination from ES-somatic hybrid cells. Nat Methods, 4(1), 23-25.
8. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-676.
9. Maherali, N., Sridharan, R., Xie, W., et al. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell, 1(1), 55-70.
10. Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448(7151), 313-317.
11. Wernig, M., Meissner, A., Cassady, J. P., & Jaenisch, R. (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell, 2(1), 10-12.
12. Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861-872.
13. Yu, J., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917-1920.
14. Park, I. H., Zhao, R., West, J. A., et al. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451(7175), 141-146.
15. Nakagawa, M., Koyanagi, M., Tanabe, K., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology, 26(1), 101-106.
16. Kim, J. B., Zaehres, H., Wu, G., et al. (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature, 454(7204), 646-650.
17. Kim, J. B., Sebastiano, V., Wu, G., et al. (2009). Oct4-induced pluripotency in adult neural stem cells. Cell, 136(3), 411-419.
18. Feng, B., Jiang, J., Kraus, P., et al. (2009). Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nature Cell Biology, 11(2), 197-203.
19. Maherali, N., & Hochedlinger, K. (2008). Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell, 3(6), 595-605.
20. Blelloch, R., Venere, M., Yen, J., & Ramalho-Santos, M. (2007). Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell, 1(3), 245-247.
21. Brambrink, T., Foreman, R., Welstead, G. G., et al. (2008). Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell, 2(2), 151-159.
22. Hockemeyer, D., Soldner, F., Cook, E. G., Gao, Q., Mitalipova, M., & Jaenisch, R. (2008). A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell, 3(3), 346-353.
23. Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C., & Hochedlinger, K. (2008). A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell, 3(3), 340-345.
24. Stadtfeld, M., Maherali, N., Breault, D. T., & Hochedlinger, K. (2008). Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell, 2(3), 230-240.
25. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008). Induced pluripotent stem cells generated without viral integration. Science, 322(5903), 945-949.
26. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322(5903), 949-953.
27. Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2008). iPS cell generation using a single lentiviral stem cell cassette. Stem Cells, 27(3), 543-549.
28. Carey, B. W., Markoulaki, S., Hanna, J., et al. (2008). Reprogramming of murine and human somatic cells using a single polycistronic vector. Proceedings of the National Academy of Sciences of the United States of America, 106(1), 157-162.
29. Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., & Woltjen, K. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458(7239), 771-775.
30. Woltjen, K., Michael, I. P., Mohseni, P., et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458(7239), 766-770.
31. Yu, J., Hu, K., Smuga-Otto, K., et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324(5928), 797-801.
32. Zhou, H., Wu, S., Joo, J. Y., et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4(5), 1-4.
33. Lowry, W. E., Richter, L., Yachechko, R., et al. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 105(8), 2883-2888.
34. Miura, K., Okada, Y., Aoi, T., et al. (2009). Variation in the safety of induced pluripotent stem cell lines. Nature Biotechnology, 27(8), 743-745.
35. Knoepfler, P. S. (2009). Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells, 27(5), 1050-1056.
36. Dimos, J. T., Rodolfa, K. T., Niakan, K. K., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321(5893), 1218-1221.
37. Ebert, A. D., Yu, J., Rose, F. F., Jr., et al. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457(7227), 277-280.
38. Park, I. H., Arora, N., Huo, H., et al. (2008). Disease-specific induced pluripotent stem cells. Cell, 134(5), 877-886.
39. Soldner, F., Hockemeyer, D., Beard, C., et al. (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136(5), 964-977.
40. Hanna, J., Wernig, M., Markoulaki, S., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318(5858), 1920-1923.
41. Ye, L., Chang, J. C., Lin, C., Sun, X., Yu, J., & Kan, Y. W. (2009). Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proceedings of the National Academy of Sciences of the United States of America, 106(24), 9826-9830.
42. Wernig, M., Zhao, J. P., Pruszak, J., et al. (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America, 105(15), 5856-5861.
43. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008). In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature, 455(7213), 627-632.
44. Erdo, F., Buhrle, C., Blunk, J., et al. (2003). Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. Journal of Cerebral Blood Flow and Metabolism, 23(7), 780-785.
45. Ford, C. E., Hamerton, J. L., Barnes, D. W., & Loutit, J. F. (1956). Cytological identification of radiation-chimaeras. Nature, 177(4506), 452-454.
46. McKay, R. (1997). Stem cells in the central nervous system. Science, 276(5309), 66-71.
47. Gage, F. H. (2000). Mammalian neural stem cells. Science, 287(5457), 1433-1438.
48. Watt, F. M. (2001). Stem cell fate and patterning in mammalian epidermis. Current Opinion in Genetics and Development, 11(4), 410-417.
49. Daniels, J. T., Dart, J. K., Tuft, S. J., & Khaw, P. T. (2001). Corneal stem cells in review. Wound Repair and Regeneration, 9(6), 483-494.
50. Slack, J. M. (1995). Developmental biology of the pancreas. Development, 121(6), 1569-1580.
51. Spradling, A., Drummond-Barbosa, D., & Kai, T. (2001). Stem cells find their niche. Nature, 414(6859), 98-104.
52. Alonso, L., & Fuchs, E. (2003). Stem cells of the skin epithelium. Proceedings of the National Academy of Sciences of the United States of America, 100(Suppl 1), 11830-11835.
53. Blau, H. M., Brazelton, T. R., & Weimann, J. M. (2001). The evolving concept of a stem cell: entity or function? Cell, 105(7), 829-841.
54. McGuckin, C. P., & Forraz, N. (2008). Potential for access to embryonic-like cells from human umbilical cord blood. Cell Proliferation, 41(Suppl 1), 31-40.
55. Rocha, V., Wagner, J. E., Jr., Sobocinski, K. A., et al. (2000). Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and international bone marrow transplant registry working committee on alternative donor and stem cell sources. The New England Journal of Medicine, 342(25), 1846-1854.
56. Rubinstein, P., Adamson, J. W., & Stevens, C. (1999). The placental/umbilical cord blood program of the New York blood center. A progress report. Annals of the New York Academy of Sciences, 872, 328-334. discussion 34-5.
57. Cohen, Y., & Nagler, A. (2004). Umbilical cord blood transplantation-how, when and for whom? Blood Reviews, 18(3), 167-179.
58. Liu, E., Law, H. K., & Lau, Y. L. (2004). Tolerance associated with cord blood transplantation may depend on the state of host dendritic cells. British Journal Haematology, 126(4), 517-526.
59. Gilmore, G. L., DePasquale, D. K., Lister, J., & Shadduck, R. K. (2000). Ex vivo expansion of human umbilical cord blood and peripheral blood CD34(+) hematopoietic stem cells. Experimental Hematology, 28(11), 1297-1305.
60. Ende, N., Lu, S., Alcid, M. G., Chen, R., & Mack, R. (2001). Pooled umbilical cord blood as a possible universal donor for marrow reconstitution and use in nuclear accidents. Life Sciences, 69(13), 1531-1539.
61. Querol, S., Capmany, G., Azqueta, C., et al. (2000). Direct immunomagnetic method for CD34+ cell selection from cryopreserved cord blood grafts for ex vivo expansion protocols. Transfusion, 40(6), 625-631.
62. Forraz, N., Pettengell, R., Deglesne, P. A., & McGuckin, C. P. (2002). AC133+ umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis. British Journal Haematology, 119(2), 516-524.
63. McGuckin, C. P., Pearce, D., Forraz, N., Tooze, J. A., Watt, S. M., & Pettengell, R. (2003). Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. European Journal of Haematology, 71(5), 341-350.
64. Baal, N., Reisinger, K., Jahr, H., et al. (2004). Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thrombosis and Haemostasis, 92(4), 767-775.
65. Kucia, M., Halasa, M., Wysoczynski, M., et al. (2007). Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia, 21(2), 297-303.
66. Kucia, M., Reca, R., Campbell, F. R., et al. (2006). A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia, 20(5), 857-869.
67. Ratajczak, M. Z., Zuba-Surma, E. K., Shin, D. M., Ratajczak, J., & Kucia, M. (2008). Very small embryonic-like (VSEL) stem cells in adult organs and their potential role in rejuvenation of tissues and longevity. Experimental Gerontology, 43(11), 1009-1017.
68. McGuckin, C. P., Forraz, N., Allouard, Q., & Pettengell, R. (2004). Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Experimental Cell Research, 295(2), 350-359.
69. McGuckin, C. P., Forraz, N., Baradez, M. O., et al. (2005). Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Proliferation, 38(4), 245-255.
70. Denner, L., Bodenburg, Y., Zhao, J. G., et al. (2007). Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Proliferation, 40(3), 367-380.
71. Jurga, M., Lipkowski, A. W., Lukomska, B., Buzanska, L., Kurzepa, K., Sobanski, T., et al. (2009). Generation of functional neural artificial tissue from human umbilical cord blood stem cells. Tissue Engineering Part C Methods, 15(3), 365-372. http://www. ncbi. nlm. nih. gov/pubmed/19719393?itool=EntrezSystem2. PEntrez. Pubmed. Pubmed_ResultsPanel. Pubmed_RVDocSum& ordinalpos=1.
72. Ali, H., Jurga, M., Kurgonaite, K., Forraz, N., & McGuckin, C. (2009). Defined serum-free culturing conditions for neural tissue engineering of human cord blood stem cells. Acta Neurobiologiae Experimentalis, 69(1), 12-23.
73. Zhao, Y., Wang, H., & Mazzone, T. (2006). Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Experimental Cell Research, 312(13), 2454-2464.
74. Sun, B., Roh, K. H., Lee, S. R., Lee, Y. S., & Kang, K. S. (2007). Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure. Biochemical and Biophysical Research Communications, 354(4), 919-923.
75. Yoshida, S., Ishikawa, F., Kawano, N., et al. (2005). Human cord blood-derived cells generate insulin-producing cells in vivo. Stem Cells, 23(9), 1409-1416.
76. van de Ven, C., Collins, D., Bradley, M. B., Morris, E., & Cairo, M. S. (2007). The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Experimental Hematology, 35(12), 1753-1765.
77. Wang, H. S., Hung, S. C., Peng, S. T., et al. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 22(7), 1330-1337.
78. Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8(9), 726-736.
79. Secco, M., Zucconi, E., Vieira, N. M., et al. (2008). Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells, 26(1), 146-150.
80. Secco, M., Zucconi, E., Vieira, N. M., et al. (2008). Mesenchymal stem cells from umbilical cord: do not discard the cord! Neuromuscular Disorders, 18(1), 17-18.
81. Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics, 3(4), 393-403.
82. Romanov, Y. A., Svintsitskaya, V. A., & Smirnov, V. N. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells, 21(1), 105-110.
83. Sarugaser, R., Lickorish, D., Baksh, D., Hosseini, M. M., & Davies, J. E. (2005). Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells, 23(2), 220-229.
84. Ma, L., Feng, X. Y., Cui, B. L., et al. (2005). Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. Chinese Medical Journal (Engl), 118(23), 1987-1993.
85. Mitchell, K. E., Weiss, M. L., Mitchell, B. M., et al. (2003). Matrix cells from Wharton's jelly form neurons and glia. Stem Cells, 21(1), 50-60.
86. Lu, L. L., Liu, Y. J., Yang, S. G., et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 91(8), 1017-1026.
87. Fong, C. Y., Richards, M., Manasi, N., Biswas, A., & Bongso, A. (2007). Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reproductive Biomedicine Online, 15(6), 708-718.
88. Jo, C. H., Kim, O. S., Park, E. Y., et al. (2008). Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell and Tissue Research, 334(3), 423-433.
89. Karahuseyinoglu, S., Cinar, O., Kilic, E., et al. (2007). Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells, 25(2), 319-331.
90. Kermani, A. J., Fathi, F., & Mowla, S. J. (2008). Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy. Rejuvenation Research, 11(2), 379-386.
91. Sohrabji, F., & Lewis, D. K. (2006). Estrogen-BDNF interactions: implications for neurodegenerative diseases. Frontiers in Neuroendocrinology, 27(4), 404-414.
92. Yaghoobi, M. M., & Mowla, S. J. (2006). Differential gene expression pattern of neurotrophins and their receptors during neuronal differentiation of rat bone marrow stromal cells. Neuroscience Letters, 397(1-2), 149-154.
93. Ende, M., & Ende, N. (1972). Hematopoietic transplantation by means of fetal (cord) blood. A new method. Virginia Medical Monthly (1918), 99(3), 276-80.
94. Gluckman, E., & Rocha, V. (2009). Cord blood transplantation: state of the art. Haematologica, 94(4), 451-454.
95. Wagner, J. E., Barker, J. N., DeFor, T. E., et al. (2002). Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood, 100(5), 1611-1618.
96. Locatelli, F., Rocha, V., Reed, W., et al. (2003). Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood, 101(6), 2137-2143.
97. Gluckman, E., Rocha, V., Boyer-Chammard, A., et al. (1997). Outcome of cord-blood transplantation from related and unrelated donors. Eurocord transplant group and the European blood and marrow transplantation group. The New England Journal of Medicine, 337(6), 373-381.
98. Rubinstein, P., Carrier, C., Scaradavou, A., et al. (1998). Outcomes among 562 recipients of placental-blood transplants from unrelated donors. The New England Journal of Medicine, 339(22), 1565-1577.
99. Kurtzberg, J., Laughlin, M., Graham, M. L., et al. (1996). Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. The New England Journal of Medicine, 335(3), 157-166.
100. Wagner, J. E., Rosenthal, J., Sweetman, R., et al. (1996). Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood, 88(3), 795-802.
101. Laughlin, M. J., Barker, J., Bambach, B., et al. (2001). Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. The New England Journal of Medicine, 344(24), 1815-1822.
102. Barker, J. N., Davies, S. M., DeFor, T., Ramsay, N. K., Weisdorf, D. J., & Wagner, J. E. (2001). Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood, 97(10), 2957-2961.
103. Laughlin, M. J., Eapen, M., Rubinstein, P., et al. (2004). Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. The New England Journal of Medicine, 351(22), 2265-2275.
104. Rocha, V., Labopin, M., Sanz, G., et al. (2004). Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. The New England Journal of Medicine, 351(22), 2276-2285.
105. Hwang, W. Y., Samuel, M., Tan, D., Koh, L. P., Lim, W., & Linn, Y. C. (2007). A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biology of Blood and Marrow Transplantation, 13(4), 444-453.
106. Gluckman, E., & Rocha, V. (2006). Donor selection for unrelated cord blood transplants. Current Opinion in Immunology, 18(5), 565-570.
107. Harris, D. T. (2009). Non-haematological uses of cord blood stem cells. British Journal Haematology, 147(2), 177-184.
108. Advani, A. S., & Laughlin, M. J. (2009). Umbilical cord blood transplantation for acute myeloid leukemia. Current Opinion in Hematology, 16(2), 124-128.
109. Kurtzberg, J. (2009). Update on umbilical cord blood transplantation. Current Opinion in Pediatrics, 21(1), 22-29.
110. Harris, D. T. (2008). Cord blood stem cells: a review of potential neurological applications. Stem Cell Reviews, 4(4), 269-274.
111. Tse, W., Bunting, K. D., & Laughlin, M. J. (2008). New insights into cord blood stem cell transplantation. Current Opinion in Hematology, 15(4), 279-284.
112. Giorgetti, A., Montserrat, N., Aasen, T., et al. (2009). Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell, 5(4), 353-357.
113. Haase, A., Olmer, R., Schwanke, K., et al. (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell, 5(4), 434-441.
114. Ohnuma, K., Isoyama, K., Ikuta, K., et al. (2001). Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies. British Journal Haematology, 112(4), 981-987.
115. Paquette, R. L., Dergham, S. T., Karpf, E., et al. (2000). Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood, 96(7), 2385-2390.
116. Nieboer, P., de Vries, E. G., Mulder, N. H., et al. (2001). Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours. Bone Marrow Transplantation, 27(9), 959-966.
117. Voltarelli, J. C., Couri, C. E., Stracieri, A. B., et al. (2007). Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. Jama, 297(14), 1568-1576.
118. Burt, R. K., Traynor, A., Statkute, L., et al. (2006). Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. Jama, 295(5), 527-535.
119. Burt, R. K., Oyama, Y., Verda, L., et al. (2004). Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis and Rheumatism, 50(8), 2466-2470.
120. Saccardi, R., Mancardi, G. L., Solari, A., et al. (2005). Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood, 105(6), 2601-2607.
121. Grunebaum, E., Mazzolari, E., Porta, F., et al. (2006). Bone marrow transplantation for severe combined immune deficiency. Jama, 295(5), 508-518.
122. Ziegner, U. H., Ochs, H. D., Schanen, C., et al. (2001). Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. The Journal of Pediatrics, 138(4), 570-573.
123. Klein, A., Brachet, C., Azzi, N., & Ferster, A. (2005). Hematopoietic stem cell transplantation for severe sickle cell disease. Revue médicale de Bruxelles, 26 Spec no, Sp23-5.
124. Ayas, M., Al-Jefri, A., Mustafa, M. M., Al-Mahr, M., Shalaby, L., & Solh, H. (2001). Congenital sideroblastic anaemia successfully treated using allogeneic stem cell transplantation. British Journal Haematology, 113(4), 938-939.
125. Gurman, G., Celebi, H., Ustun, C., et al. (2001). Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia. Therapeutic Apheresis, 5(1), 54-57.
126. Inatomi, T., Nakamura, T., Koizumi, N., Sotozono, C., Yokoi, N., & Kinoshita, S. (2006). Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation. American Journal of Ophthalmology, 141(2), 267-275.
127. Nishida, K., Yamato, M., Hayashida, Y., et al. (2004). Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. The New England Journal of Medicine, 351(12), 1187-1196.
128. Badiavas, E. V., & Falanga, V. (2003). Treatment of chronic wounds with bone marrow-derived cells. Archives of Dermatology, 139(4), 510-516.
129. Blocklet, D., Toungouz, M., Berkenboom, G., et al. (2006). Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells, 24(2), 333-336.
130. Janssens, S., Dubois, C., Bogaert, J., et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet, 367(9505), 113-121.
131. Patel, A. N., Geffner, L., Vina, R. F., et al. (2005). Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. Journal of Thoracic and Cardiovascular Surgery, 130(6), 1631-1638.
132. Bartunek, J., Vanderheyden, M., Vandekerckhove, B., et al. (2005). Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation, 112(9 Suppl), I178-I183.
133. Dohmann, H. F., Perin, E. C., Takiya, C. M., et al. (2005). Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation, 112(4), 521-526.
134. Strauer, B. E., Brehm, M., Zeus, T., et al. (2005). Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. Journal of the American College of Cardiology, 46(9), 1651-1658.
135. Shyu, W. C., Lin, S. Z., Lee, C. C., Liu, D. D., & Li, H. (2006). Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. Cmaj, 174(7), 927-933.
136. Stilley, C. S., Ryan, C. M., Kondziolka, D., Bender, A., DeCesare, S., & Wechsler, L. (2004). Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke. Neurology, 63(7), 1320-1322.
137. Meltzer, C. C., Kondziolka, D., Villemagne, V. L., et al. (2001). Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery, 49(3), 586-91. discussion 591-2.
138. Lima, C., Pratas-Vital, J., Escada, P., Hasse-Ferreira, A., Capucho, C., & Peduzzi, J. D. (2006). Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med, 29(3), 191-203. discussion 204-6.
139. Bauchet, L., Lonjon, N., Perrin, F. E., Gilbert, C., Privat, A., & Fattal, C. (2009). Strategies for spinal cord repair after injury: a review of the literature and information. Annals of Physical and Rehabilitation Medicine, 52(4), 330-351. http://www. ncbi. nlm. nih. gov/pubmed/19081649?itool=EntrezSystem2. PEntrez. Pubmed. Pubmed_ResultsPanel. Pubmed_RVDocSum& ordinalpos=1.
140. Terai, S., Ishikawa, T., Omori, K., et al. (2006). Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells, 24(10), 2292-2298.
141. Gordon, M. Y., Levicar, N., Pai, M., et al. (2006). Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells, 24(7), 1822-1830.
142. Macchiarini, P., Jungebluth, P., Go, T., et al. (2008). Clinical transplantation of a tissue-engineered airway. Lancet, 372(9655), 2023-2030.